Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1990-05-03
1992-08-04
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 78, A61K 31685
Patent
active
051359219
ABSTRACT:
We describe the use of phospholipidic carnitine derivatives of general formula ##STR1## in their racemic or optically active form, wherein R.sub.1 and R.sub.2, equal or different, are radicals of linear or branched, saturated or monoor poly-unsaturated, aliphatic acids with 1 to 20 C for the preparation of pharmaceutical compositions having an activity as reproductive agent of the nerve fibers in the therapy of human pathologies associated with neuronal damages, more particularly in the therapy of peripheral neuropathies, of cerebrovascular diseases, of cerebral level traumas and of chronic neurodegenerative diseases.
REFERENCES:
patent: 4343816 (1982-08-01), Cavazza
patent: 4346107 (1982-08-01), Cavazza et al.
patent: 4439438 (1984-03-01), Cavazza
Hintze, V et al. Lipids 10(1): 20-24 (1975).
Curti, D et al. Biological Psychiatry (1985).
Tempesta, JL Int. J. Clin. Pharm. Res. 3(4): 295-306 (1983).
della Valle Francesco
Romeo Aurelio
FIDIA S.p.A.
Hollinden Gary E.
Hollrah Glennon H.
LandOfFree
Pharmaceutical compositions comprising phosphatidyl carnitine fo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising phosphatidyl carnitine fo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising phosphatidyl carnitine fo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-778429